These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4717021)

  • 1. Effect of 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF 525-A) on sulphacetamide distribution and excretion in rats.
    Marchand C; Nadeau D
    Br J Pharmacol; 1973 Jan; 47(1):69-76. PubMed ID: 4717021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in the kinetics of sulphacetamide tissue distribution in Walker tumor-bearing rats.
    Nadeau D; Marchand C
    Drug Metab Dispos; 1975; 3(6):565-76. PubMed ID: 1234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of SKF 525-A on drug absorption in rats.
    Hayton WL; Levy G
    Life Sci I; 1971 Jun; 10(12):691-7. PubMed ID: 5556757
    [No Abstract]   [Full Text] [Related]  

  • 4. The distribution and kinetics of sulphacetamide in leukaemic mice.
    Marchand C; Nadeau D
    Br J Pharmacol; 1976 Apr; 56(4):423-9. PubMed ID: 1260222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of SKF 525-A on drug concentration in the blood.
    McLean S; Marchand C
    Life Sci I; 1970 Sep; 9(18):1075-80. PubMed ID: 5478409
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of SKF 525A on the distribution of carbon tetrachloride in rats.
    Marchand C; McLean S; Plaa GL
    J Pharmacol Exp Ther; 1970 Aug; 174(2):232-8. PubMed ID: 5451360
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased plasma enzyme activity induced by 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF 525-A).
    Koff RS; Fitts JJ
    Biochem Pharmacol; 1972 Apr; 21(7):1053-5. PubMed ID: 5039749
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of cimetidine and diethylaminoethyl 2,2-diphenylvalerate HCL (SKF 525-A) on trimethadione metabolism in the rat.
    Tanaka E; Misawa S; Kuroiwa Y
    J Pharmacobiodyn; 1985 Sep; 8(9):767-72. PubMed ID: 4087136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the drug-metabolizing enzymes' induction by 2-diethylaminoethyl-2-2-diphenylvalerate-HCl (SKF 525 A).
    Fernández G; Villarruel MC; Castro JA
    Toxicol Appl Pharmacol; 1978 Nov; 46(2):315-21. PubMed ID: 734661
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of co-administration of monomethylaminoantipyrine with diethylaminoethyl 2,2-diphenylvalerate (SKF 525-A) on gamma-glutamyltranspeptidase, glutathione S-transferase and hepatic drug metabolizing enzyme activities in rats.
    Hoshi K; Senda N; Igarashi T; Satoh T; Ueno K; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):71-80. PubMed ID: 2872706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of 2-diethylaminoethyl 2,2-diphenylvalerate hydrochloride (SKF 525-A) on aromatic hydroxylation and phenolic glucuronidation.
    Ikeda M; Tanaka S; Katayama T
    Mol Pharmacol; 1968 Jan; 4(1):38-43. PubMed ID: 5640778
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of drug metabolism. IV. Induction of drug metabolism by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and 2,4-dichloro-6-phenylphenoxyethylamine HBr (Lilly 18947) and the effect of induction on the inhibitory properties of SKF 525-A type compounds.
    Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):341-6. PubMed ID: 5968074
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of drug metabolism. I. Kinetics of the inhibition of the N-demethylation of ethylmorphine by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and related compounds.
    Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):319-27. PubMed ID: 5968071
    [No Abstract]   [Full Text] [Related]  

  • 15. The delay of the behavioral effects of 9 -tetrahydrocannabinol in rats by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A).
    Peterson DW; Cohen GM; Sparber SB
    Life Sci I; 1971 Dec; 10(24):1381-6. PubMed ID: 5146321
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of an inhibitor of hepatic drug metabolism, 2-diethylaminoethyl-2,2-diphenylvalerate HCl (SKF 525-A), on thyroxine metabolism in the rat.
    Nakamura Y; Bellamy G; Green WL
    Endocrinology; 1981 Apr; 108(4):1519-36. PubMed ID: 7472282
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 2-diethylaminoethyl-2.2-diphenylvalerate hydrochloride on the uterotropic action of o.p'-DDT.
    Zeitoun R; Makar AB
    Pharmazie; 1973 Oct; 28(10):673-5. PubMed ID: 4783554
    [No Abstract]   [Full Text] [Related]  

  • 18. Degradation studies on sulphacetamide eye-drops. Part 2: Spectrophotometric evaluation of decomposition products of UV-irradiated solutions of sulphacetamide.
    Ahmad T
    Pharmazie; 1982 Aug; 37(8):559-61. PubMed ID: 7146062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution in the rabbit of choline administered by injection or infusion.
    Gardiner JE; Gwee MC
    J Physiol; 1974 Jun; 239(3):459-76. PubMed ID: 4854729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of levo-methadone in nonpregnant and pregnant female and male mice: effect of SKF 525-A 1,2.
    Shah NS; Donald AG; Bertolatus JA; Hixson B
    J Pharmacol Exp Ther; 1976 Oct; 199(1):103-16. PubMed ID: 978473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.